Human KIR2DL1/KIR2DL3/KIR2DL4 antibody

Killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 4, Killer cell immunoglobulin-like receptor 2DL4, CD158 antigen-like family member D, G9P, Killer cell inhibitory receptor 103AS, KIR-103AS, MHC class I NK cell receptor KIR103AS, CD158D, KIR103AS,103AS, 15.212

KIR2DL1, P43626, NP_055033, KIR2DL3, P43628, NP_056952.2, killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 1, Killer cell immunoglobulin-like receptor 2DL1, CD158 antigen-like family member A, Natural killer-associated transcript 1, NKAT-1, p58 natural killer cell receptor clones CL-42/47.11, p58 NK receptor CL-42/47.11, p58.1 MHC class-I-specific NK receptor, CD158a, Killer cell immunoglobulin-like receptor 2DL3, CD158 antigen-like family member B2, KIR-023GB, Killer inhibitory receptor cl 2-3, NKAT2a, NKAT2b, Natural killer-associated transcript 2, NKAT-2, p58 natural killer cell receptor clone CL-6, p58 NK receptor CL-6, p58.2 MHC class-I-specific NK receptor, CD158b2, KIRCL23, KIR2DL4, CD158d, AKR0501-10 µg, AKR0501-20 µg, AKR0501-50 µg, AKR0501-100 µg, AKR0501-250 µg, AKR0501-500 µg, AKR0501-1 mg, AKR0501-010, AKR0501-020, AKR0501-050, AKR0501-100, AKR0501-250, AKR0501-500, AKR0501-01M

The antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results.

The recombinant proteins (20ng) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human kIR2D (1:500) . Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and a ECL detection system.; ; Lane 1.: Recombinant human kIR2DL1 protein (23-223aa) ; ; Lane 2.: Recombinant human kIR2DL3 protein (23-223aa) ; ; Lane 3.: Recombinant human kIR2DL4 protein (44-202aa)